ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,420Medicare Part D Prescriptions Filled, Including Refills

Rank: 166 out of 2035

$435K Total Retail Price of All Prescriptions

Rank: 405 out of 2035

276 Patients Receiving at Least One Drug in Part D
39%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

51% of this provider’s 276 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 4,874 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
HYDROCODONE-ACETAMINOPHEN 827 327 S3 1 2
SIMVASTATIN 532 261 2 1
PROAIR HFA 401 158 3 31
LISINOPRIL 393 185 4 3
OMEPRAZOLE 353 97 5 5
AMLODIPINE BESYLATE 284 159 6 6
RANITIDINE HCL 267 143 7 28
HYDROCHLOROTHIAZIDE 251 123 8 12
FUROSEMIDE 243 117 9 7
GABAPENTIN 233 93 10 14
METOPROLOL TARTRATE 223 98 11 8
METFORMIN HCL 189 101 12 9
POTASSIUM CHLORIDE 164 50 13 18
ISOSORBIDE MONONITRATE ER 164 93 13 32
SPIRIVA 162 91 15 44
HYDRALAZINE HCL 137 70 16 45
ENALAPRIL MALEATE 124 77 17 60
CYCLOBENZAPRINE HCL 117 29 R 18 64
ALLOPURINOL 114 75 19 34
ALENDRONATE SODIUM 110 82 20 27
CLOPIDOGREL 104 66 21 30
ADVAIR DISKUS 99 49 22 38
PREDNISONE 99 44 22 36
FLUTICASONE PROPIONATE 90 32 24 29
LANTUS 89 59 25 40
IBUPROFEN 88 12 26 43
METOPROLOL SUCCINATE 86 50 27 16
VENTOLIN HFA 83 58 28 80
CARVEDILOL 75 59 29 22
OXYBUTYNIN CHLORIDE 73 33 30 102
ATROVENT HFA 70 22 31 292
QVAR 69 0 32 234
SPIRONOLACTONE 68 39 33 65
DILTIAZEM 24HR ER 68 23 33 143
LYRICA 65 11 35 89
LEVOTHYROXINE SODIUM 65 44 35 4
NOVOLOG 63 17 37 95
PLAVIX 62 51 38 49
CHLORTHALIDONE 61 0 39 145
LOSARTAN POTASSIUM 60 33 40 15
COLCRYS 59 37 41 186
WARFARIN SODIUM 57 34 42 11
SURE COMFORT 57 22 42 243
CARISOPRODOL 56 0 R 44 57
AMITRIPTYLINE HCL 55 34 R 45 101
SURE COMFORT ALCOHOL 55 15 45 362
KLOR-CON M20 54 20 47 73
LEVETIRACETAM 53 22 48 87
GEMFIBROZIL 52 24 49 114
GLIPIZIDE 52 27 49 54
NITROSTAT 50 40 51 167
ATENOLOL 50 29 51 10
TRIAMTERENE-HCTZ 50 46 51 35
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 15, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.